Evidence map›Paper›PMID 31191488›Full record

ArticleFrontiers in microbiology2019

Stepwise Development of an

Sophie A Poeker, Christophe Lacroix, Tomas de Wouters, Marianne R Spalinger, Michael Scharl, Annelies Geirnaert

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Frontiers in microbiology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The Game for Three:Frontiers in microbiology · 2022
    Review
  8. A Comprehensive Evaluation ofPathogens (Basel, Switzerland) · 2021
    Article
  9. Article
  10. ACS synthetic biology · 2021
    Article
  11. mSystems · 2021
    Article
  12. Frontiers in microbiology · 2021
    Article
  13. GABA Production by Human IntestinalFrontiers in microbiology · 2021
    Article
  14. Yeast Fermentate-Mediated Reduction ofFrontiers in microbiology · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sophie A PoekerLaboratory of Food Biotechnology, Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.
Christophe LacroixLaboratory of Food Biotechnology, Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.
Tomas de WoutersLaboratory of Food Biotechnology, Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.
Marianne R SpalingerDepartment of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Michael ScharlDepartment of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Annelies GeirnaertLaboratory of Food Biotechnology, Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Murine models are valuable tools to study the role of gut microbiota in health or disease. However, murine and human microbiota differ in species composition, so further investigation of the murine gut microbiota is important to gain a better mechanistic understanding. Continuous

Indexed as

C57BL/6cultivationin vitro modelmicrobiomemouse caecum

Identifiers

PMID31191488
PMCPMC6548829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.